Opko Health, Inc. Completes Acquisition of FineTech Pharmaceutical, Ltd.
MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE: OPK) announced that it has completed the acquisition of FineTech Pharmaceutical Ltd., a profitable Israeli company which develops and produces high value, high potency active pharmaceutical ingredients (APIs) using its proprietary technology and know-how in complex organic syntheses.